Company intelligence / Profile preview

Chemizon

Ownership: Private
Development stage: Other

Overview

Chemizon operated as a global drug discovery services company, providing integrated platforms to help convert research discoveries into small molecule therapeutics. The company focused primarily on oncology and infectious diseases, collaborating with academic institutions such as KRIBB to develop novel protein, antibody, and small molecule drugs. There is no evidence of clinical-stage programs or commercialized products; the company's activities were centered around target validation, proteomics, biomarkers, translational medicine research, and stem cell biology in the preclinical stage[5][6][7].

Therapeutic areas: OncologyInfectious Diseases
Modalities: Small moleculeProteinAntibody
Industry: Drug Discovery Services

Partnerships

Korea Research Institute of Bioscience & Biotechnology (KRIBB)

Beyond the preview

Go deeper on Chemizon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemizon.

Explore the full profile